Skip to main content
TipRanks
Go Ultimate75% OFF

Fennec Pharmaceuticals (RV41) Q2 2026 Earnings Report

0 Followers

DE:RV41 Q2 2026 EPS Results

Actual EPS
EUR 0.05
Consensus EPS
EUR 0.02
Beat/Miss
Beat by +EUR 0.03
One Year Ago EPS
-EUR 0.10

DE:RV41 Q2 2026 Revenue Results

Actual Revenue
EUR 16.22M
Expected Revenue
EUR 14.70M
Beat/Miss
Beat by +EUR 1.51M
YoY Revenue Growth
+85.18%

Earnings Announcement Details

Quarter
Q2 2026
Date
08/11/2026
Time
Before Open
Conference Call
Tuesday, August 11, 2026
DE:RV41 Upcoming Earnings

Fennec Pharmaceuticals's next earnings date is estimated for March 30, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DE:RV41 Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:RV41 Earnings History

DE:RV41 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 30, 20272026 (Q4)0.14--0.15――
Nov 12, 20262026 (Q3)0.090.11-0.02700.00% (+0.13)
Aug 11, 20262026 (Q2)0.020.05-0.1145.45% (+0.15)
May 14, 20262026 (Q1)-0.040.01-0.04125.00% (+0.05)
Mar 24, 20262025 (Q4)0.04-0.15-0.05-183.33% (-0.10)
Nov 13, 20252025 (Q3)-0.02-0.02-0.1990.48% (+0.17)
Aug 14, 20252025 (Q2)-0.03-0.10-0.1845.00% (+0.08)
May 13, 20252025 (Q1)-0.08-0.040.37-109.76% (-0.41)
Mar 10, 20252024 (Q4)-0.12-0.05-0.0940.00% (+0.04)
Nov 07, 20242024 (Q3)-0.08-0.19-0.06-200.00% (-0.13)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed